Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Xue

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
BJU International|November 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinomaXin An, Cong Xue, Meiting Chen, et al.
Medicine|November 12, 2015
The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung CancerYaxiong Zhang, Dacheng He, Wenfeng Fang, et al.
Cancer Research and Treatment|October 17, 2023
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective StudyKuikui Jiang, Ruoxi Hong, Wen Xia, et al.
Drug Design, Development and Therapy|October 23, 2014
Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivoYuan-Yuan Zhao, Ying Tian, Jing Zhang, et al.
World Journal of Gastrointestinal Surgery|September 13, 2023
Anti-reflux effects of a novel esophagogastric asymmetric anastomosis technique after laparoscopic proximal gastrectomyLi-Qun Pang, Jie Zhang, Fang Shi, et al.
Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.
Chinese Journal of Cancer|May 13, 2015
Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinomaJian-Wei Zhang, Tao Qin, Shao-Dong Hong, et al.
Cancer Communications (London, England)|February 2, 2021
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I studyRuoxi Hong, Wen Xia, Liye Wang, et al.
NPJ Breast Cancer|June 13, 2024
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasisDongshao Chen, Fei Xu, Yongkui Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Olanzapine combined with standard antiemetics for the prevention of nausea and vomiting in patients with germ cell tumor undergoing a 5-day cisplatin-based chemotherapy (NAVIGATE study)： A phase III crossover trialLulu Zhang, Meiting Chen, Qingru Zhou, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
BJU International|November 27, 2023
Gemcitabine/nab-paclitaxel vs gemcitabine/carboplatin for advanced urothelial carcinomaXin An, Cong Xue, Meiting Chen, et al.
Medicine|November 12, 2015
The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung CancerYaxiong Zhang, Dacheng He, Wenfeng Fang, et al.
Cancer Research and Treatment|October 17, 2023
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective StudyKuikui Jiang, Ruoxi Hong, Wen Xia, et al.
Drug Design, Development and Therapy|October 23, 2014
Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivoYuan-Yuan Zhao, Ying Tian, Jing Zhang, et al.
World Journal of Gastrointestinal Surgery|September 13, 2023
Anti-reflux effects of a novel esophagogastric asymmetric anastomosis technique after laparoscopic proximal gastrectomyLi-Qun Pang, Jie Zhang, Fang Shi, et al.
Oncotarget|September 18, 2015
High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancerTao Qin, Yin-duo Zeng, Ge Qin, et al.
Chinese Journal of Cancer|May 13, 2015
Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinomaJian-Wei Zhang, Tao Qin, Shao-Dong Hong, et al.
Cancer Communications (London, England)|February 2, 2021
Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2-positive breast cancer: An open-label, dose-escalation, phase I studyRuoxi Hong, Wen Xia, Liye Wang, et al.
NPJ Breast Cancer|June 13, 2024
Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasisDongshao Chen, Fei Xu, Yongkui Lu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 2025
Olanzapine combined with standard antiemetics for the prevention of nausea and vomiting in patients with germ cell tumor undergoing a 5-day cisplatin-based chemotherapy (NAVIGATE study)： A phase III crossover trialLulu Zhang, Meiting Chen, Qingru Zhou, et al.
Pageof 16